Site Map
Product Pages Catalogue Numbers 0801 - 0900
| Cat. No. | Product Name & Pharmacological Action |
|---|---|
| 0803 | MSOP |
| Specific group III mGlu antagonist | |
| 0805 | (S)-3,5-DHPG |
| Active enantiomer of (0342) | |
| 0806 | Gabapentin |
| Anticonvulsant. Increases brain GABA | |
| 0807 | THIP hydrochloride |
| GABAA agonist | |
| 0808 | Vigabatrin |
| GABA-T inhibitor | |
| 0811 | (±)-threo-3-Methylglutamic acid |
| EAAT2 and EAAT4 blocker | |
| 0817 | (2R,3S)-Chlorpheg |
| Weak NMDA antagonist | |
| 0820 | ICI 174,864 |
| δ selective peptide antagonist | |
| 0821 | ICI 118,551 hydrochloride |
Very selective β2 antagonist |
|
| 0822 | ICI 204,448 hydrochloride |
| κ agonist, acts peripherally | |
| 0823 | ICI 216,140 |
| Potent Bombesin/Gastrin releasing peptide antagonist | |
| 0824 | Clofibrate |
| PPAR agonist | |
| 0825 | Clofibric acid |
| PPAR agonist | |
| 0826 | Tiotidine |
| Potent, selective H2 antagonist | |
| 0827 | ICI 154,129 |
| δ selective peptide antagonist | |
| 0829 | Pronethalol hydrochloride |
β antagonist |
|
| 0830 | Primidone |
| Potentiates GABAA receptor function | |
| 0831 | Practolol |
β1 antagonist |
|
| 0832 | ICI 89406 |
β antagonist |
|
| 0833 | ICI 162,846 |
| Potent H2 antagonist, active in vivo | |
| 0834 | (S)-(-)-Propranolol hydrochloride |
More active enantiomer |
|
| 0835 | (R)-(+)-Propranolol hydrochloride |
Less active enantiomer |
|
| 0836 | ICI 185,282 |
| Potent thromboxane receptor antagonist | |
| 0837 | ICI 192,605 |
| Potent thromboxane A2/TP receptor antagonist | |
| 0839 | DHBP dibromide |
| Ca2+ release inhibitor | |
| 0840 | Loperamide hydrochloride |
| Peripherally acting μ agonist. Also Ca2+ channel blocker | |
| 0841 | DTG |
| High affinity ligand (σ1 = σ2) | |
| 0842 | Agmatine sulfate |
α2 ligand. Also imidazoline ligand |
|
| 0843 | Oxotremorine sesquifumarate |
Muscarinic agonist |
|
| 0845 | Evans Blue tetrasodium salt |
| Potent inhibitor of L-glutamate uptake into synaptic vesicles | |
| 0846 | Chicago Sky Blue 6B |
| Potent inhibitor of L-glutamate uptake into synaptic vesicles | |
| 0847 | Statil |
| Aldose reductase inhibitor | |
| 0851 | Propranolol glycol |
Propranolol metabolite |
|
| 0853 | MPPG |
| Group III/group II mGlu antagonist. More selective for group III than group II | |
| 0854 | MSPG |
| Group II/group III mGlu antagonist | |
| 0855 | MTPG |
| Group II/group III mGlu antagonist. More selective for group II than group III | |
| 0860 | tADA |
| Group I agonist; some mGlu5 selectivity | |
| 0864 | GR 46611 |
| 5-HT1D agonist | |
| 0867 | Aniracetam |
| Desensitization inhibitor (AMPA > kainate) | |
| 0868 | L-732,138 |
| Potent, selective NK1 antagonist | |
| 0869 | Felbamate |
| NMDA antagonist, acts glycine site | |
| 0870 | MDL 11,939 |
| 5-HT2 antagonist | |
| 0871 | AMT hydrochloride |
| Potent, selective iNOS inhibitor | |
| 0872 | Cypermethrin |
| Calcineurin inhibitor (protein phosphatase 2B) | |
| 0873 | EIT hydrobromide |
| Selective iNOS inhibitor, acts arginine binding site | |
| 0875 | μ-CPP hydrochloride |
| 5-HT2B/2C receptor agonist | |
| 0876 | AM 92016 hydrochloride |
| K+ channel blocker (KV) | |
| 0877 | Luzindole |
| Competitive melatonin MT1/MT2 antagonist | |
| 0878 | Oleamide |
| Potentiator at 5-HT2A/2C receptors. Also CB1 agonist | |
| 0879 | Palmitoylethanolamide |
| Agonist for putative CB2-like receptor. FAAH and PAA substrate | |
| 0880 | ODQ |
| Selective inhibitor of NO-sensitive guanylyl cyclase | |
| 0881 | Chlormethiazole hydrochloride |
| Potentiates GABAA receptor function | |
| 0882 | ZM 226600 |
| KATP channel opener | |
| 0883 | BD 1063 dihydrochloride |
| Selective σ1 ligand, putative antagonist | |
| 0884 | Dihydrexidine hydrochloride |
Selective D1-like agonist |
|
| 0885 | Guanabenz acetate |
α2 agonist. Also I2 selective ligand |
|
| 0888 | Cirazoline hydrochloride |
| Selective α1 agonist | |
| 0889 | RS 45041-190 hydrochloride |
| High affinity I2 ligand. Highly selective | |
| 0890 | Amiloride hydrochloride |
| Na+ channel blocker. Also I2 imidazoline ligand | |
| 0891 | Rauwolscine hydrochloride |
α2 antagonist |
|
| 0892 | Naltriben mesylate |
| Standard δ2 selective antagonist | |
| 0894 | (RS)-(±)-Sulpiride |
Standard selective D2-like antagonist |
|
| 0895 | (S)-(-)-Sulpiride |
Standard selective D2-like antagonist |
|
| 0896 | GR 135531 |
| High affinity melatonin MT3 ligand | |
| 0897 | S-Isopropylisothiourea hydrobromide |
| iNOS inhibitor, acts arginine binding site | |
| 0899 | BNTX maleate |
| Standard δ1 selective antagonist | |
| 0900 | MRS 2179 tetrasodium salt |
| Selective P2Y1 antagonist | |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | All |
[top]